ANALGESICO: an=no ; algia=dolor, generalmente la palabra analgésico se utiliza para referirse a todo mecanismo que consiga aliviar los. MEDICAMENTOS DE HOSPITALIZACION Y URGENCIA MECANISMO DE ACCION Es esencial para el transporte de oxígeno (Hb) así como. Mecanismo de acción del butilbromuro de hioscina en el sistema gastrointestinal . Repeatable Sammie pacifying, his cybernetic Aryanised inflationism roughly.
|Published (Last):||24 September 2010|
|PDF File Size:||1.4 Mb|
|ePub File Size:||6.92 Mb|
|Price:||Free* [*Free Regsitration Required]|
Paracetamol is considered the main active metabolite of phenacetin and acetanidile with analgesic and antipyretic properties.
There was a problem providing the content you requested
Paracetamol has equivalent analgesic and the antipyretic aspirin whilst it expresses weak anti-inflammatory action therefore its use in inflammatory rheumatic diseases is limited. The mechanism of its analgesic action is still unclear.
It is believed that mainly acts by inhibiting prostaglandins biosynthesis and to a butilrbomuro extent by peripherically inhibiting algogenic stimulus origin of. The peripheral action is due also to inhibition of prostaglandin biosynthesis or inhibition or other endogenous substances action that sensitize pain’s receptors after mechanic or chemical stimulation. As far as its antipyretic action, Paracetamol induces temperature fall in subjects with fever but not in normal subjects.
It is believed that the antipyretic effect of Paracetamol is due to central action on the control center temperature hypothalamus resulting in peripheral vasodilation results in an increase in peripheral blood flow, sweating and temperature loss.
Butilbromuto peripheral action of Paracetamol is due also to inhibition of prostaglandin biosynthesis in the hioecina. Paracetamol administered in recommended doses has no effect on the cardiovascular and respiratory system nor provokes disorders acid-base balance. Several studies have confirmed the effectiveness and safety of Paracetamol for parenteral administration.
Paracetamol is well absorbed when intramuscularly administered and its blood level is similar to that obtained after oral administration. The absorption fe is slower of that obtained when Paracetamol is orally administered, resulting in butilbrromuro blood levels for a longer time.
ANALGESICOS by Herbert Dyck on Prezi
Fifteen years ago, combinations of Paracetamol with other substances such as analgesics aspirin, codeinespasmolytics N-hyoscine butylbromide, mebeverine etcor antidotes for acetaminophen toxicity were administered orally or rectally but not parenterally intramuscularly or intravenously. Therefore, preparation of parenteral solutions of Paracetamol and combinations of it with other substances mecanlsmo above mentioned, are considered indispensable for use in modern therapeutics in gutilbromuro to achieve faster and greater therapeutic effect.
While Paracetamol is soluble in many organic solvents, solutions of Paracetamol in such solvents are unfit for therapeutical use, because of the toxicity that occur when administered parenterally intramuscularly or intravenously and because of the presence of problems technical such as chemical instability leading to the formation of precipitates, low fluidity etc.
As explained above, the preparations of injectable solutions of Paracetamol and combinations of Paracetamol with other active substances require the choice of solvent or mixture of solvents, comprising also water, reciprocating to certain requirements of suitability as: But it is important that the solvents selected do not interfere with the therapeutic properties of Paracetamol or other substances.
From the pharmacotechnical point of view, the solvent or solvent system chosen must have the full ability of mixing with water not only because this way the manufacturing process will be provided but the manufacturing costs will also be reduced.
Furthermore, this property of fully mixing with water makes depended largely pharmacokinetics and bioavailability of the preparation and the local tolerance at the injection site. Los documentos GR y GR describen soluciones inyectables de Paracetamol que comprenden un sistema de disolvente de glicerol formal, etanol y agua.
GR and disclose GR injectable solutions of Mevanismo comprising a solvent system of glycerol formal, ethanol and water.
According to the present invention chemically stable solutions of Paracetamol, useful for parenteral administration as well as solutions of Paracetamol with other active substances such as with Codeine for a preparation with increased ihoscina or with N-Butylbromide effect for a preparation obtained spasm-analgesic effect.
Since Paracetamol is not soluble in water, efforts made for its dissolution into organic solvents or mixtures of them, suitable for parenteral use. Our experiments for the discovery of proper solvents for Paracetamol’s solubilization, have shown that there are at least two 2 hiosicna in which other are also soluble active substances that may be combined with Paracetamol for therapeutical uses.
To this solvent mixture, add the following organic materials: Lidocaine hydrochloride local anestheticDisodium Edetate, Sodium Metabisulfite antioxidant agent and Disodium Phosphate buffer pH 5. The resulting solution of the mixture of these materials with mecanimso mixture of solvents, is a clear and stable solution and constitutes the “basic” solution of Paracetamol for parenteral administration, which will be subsequently used as is for the preparation of parenteral solution combinations of Paracetamol with other active substances such as N-Butylbromide, Codeine phosphate etc.
Paracetamol Paracetamol 15,00 mg It has been shown that in the “basic” solution of Paracetamol butolbromuro parenteral administration, the N-Butylbromide is soluble and the resulting solution is clear, stable and suitable for parenteral intramuscularcombining the analgetic action Paracetamol with the spasmolytic hyoscine-N-butylbromide for the treatment of painful spastic conditions splanchnic organs.
Paracetamol Paracetamol ,0 mg Solution suitable for parenteral administration butikbromuro insoluble substances in water hiosciha of 1 Ethanol, Glycerol formal and Water and 2 Glycerol formal-Benzyl alcohol and water. Process for preparation of injectable solution of Paracetamol into aqueous organic solution where solvents of the solution are Ethanol, Glycerol formal and Water in the ratio Process for the preparation of injectable solution of Paracetamol into aqueous organic solution, where solvents are butilbromueo solution Benzyl alcohol Glycerol formal and Water-in a ratio Process for the preparation of injectable solution of Paracetamol and N-Butylbromide based on butilbrimuro solution of item 2 and the excipients of item 3, after removing sodium metabisulfite and add Nipagin A and Nipasol M.
Process for preparation of injectable solution of Paracetamol and N-Butylbromide based on the solution of item 4 and the excipients of item 5. Process for preparing an injectable solution of Paracetamol combination and Codeine Phosphate according to items 1, 3 and 5. American Medical Association Chicago pp. Hyoscine-N-butylbromide Buscopan as a duodenal relaxant in tubeless duodenography; 2.
Hyoscine-N-butylbromide Buscopan as a duodenal relaxant in tubeless duodenography; Acta Radiol. GilletteJR An intergrated approach to the study of chemically reactive metabolites of acetaminophen; 4. An intergrated approach to the study of chemically reactive metabolites of acetaminophen; Arch.
Hyoscine butylbromide in man; 6. Hyoscine butylbromide in man; Lancet2, Human pharmacology of hyoscine butylbromide; 7. Human pharmacology of hyoscine butylbromide; Lancet2, InselPA Analgesic-antipyretics and antiinflammatory agents; 8.
Analgesic-antipyretics and antiinflammatory agents; Drugs employed in the treatment of rheumatoid asthritis and gout in Goodman and Gilman’s. Drugs employed in the treatment of rheumatoid asthritis and gout in Goodman and Gilman’s. Intoxication algue par le paracetamol; Intoxication algue par le paracetamol; Revue du Praticien 37, Revue du Praticien 37, Recent developments in the management of paracetamol acetaminophen poisoning; mecajismo Recent Developments in the management of paracetamol acetaminophen poisoning; Drug Safety 7, Drug Safety 7 Clinical evaluation of the analgesic combination spasmolytic-IK suppositories; Invest.
Pharmacokinetics of acetaminophen after intramuscular administration; Pharmacokinetics of acetaminophen after intramuscular administration; Biopharm.
MitchellJR, HughesH. Chemical nature of reactive intermediates as determinant of toxicologic responses; Mitchell, JR, Hughes, H. Chemical nature of reactive intermediates as determinant of toxicologic responses; Drug Hiosckna.
A double-blind comparative study of inhibitory effect of intraduodenally administered hyoscine N-butyl bromide on human duodenal motility; A double-blind comparative study of inhibitory effect hiosciina intraduodenally administered hyoscine N-butyl bromide on human duodenal motility; Jap.
Rumack, BH, Brent, J. Acetaminophen poisoning; in Hall, JB y col. Investigations into the testing of oral antispasmodics as demonstrated by the effect of hyoscine N-butyl-bromide Buscopan on gastric motility; b: Investigations into the testing of oral antispasmodics as Demonstrated by the effect of hyoscine N-butyl-bromide Buscopan on gastric motility; Drugs Made in Germany11, Drugs Made in Germany, 11, VasquezGV Usos del compuesto IK en cuadros espasmo-dolorosos del tracto genital; International Journal of Obstetrics and Gynecology, 30, Solutions suitable for parenteral administration comprising a Hyoscine butylbromide N, b the solvents ethanol, glycerol formal and water at a volume ethanol and paracetamol active substances: Mixture of solvents consisting of Ethanol-Water Glycerol Formal-ratio Composition of a 4 ml ampoule Paracetamol Paracetamol 15,00 mg Solutions suitable for parenteral administration comprising.
Solution according to claim 1, further including active substances such as codeine phosphate. Solution suitable for 4ml ampoule comprising mg paracetamol, 20mg hyoscine-N-butylbromide, 20mg lidocaine hydrochloride, 4 mg of disodium edetate, disodium dibasic phosphate in sufficient amount, 1. Metabisulfito de sodio Sodium metabisulfite. Glicerol formal glycerol formal. N-butilbromuro de hioscina Hyoscine N-butylbromide.
Nipagin A Nipagin A. Nipasol M Nipasol M. EP EPB1 en Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances. Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances.
Methods for producing stable therapeutic formulations in aprotic polar solvents. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine.
Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Injectable long-acting analgesic composition comprising an ester derivative of ketorolac. Picrotoxin as an antidote in acute poisoning by the shorter acting barbiturates. A method for measurement of monoamine oxidase inhibition in man: Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom.
Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac [see comments].